Abstract
Although the high prevalence of airway diseases in patients with rheumatoid arthritis (RA) has been recognized for decades, their clinical significance and treatment strategies have not been well discussed. With the introduction of potent disease-modifying treatments for RA, respiratory complications have emerged as the most important obstacle impeding the safe implementation of these therapies and improvement of patient prognosis. Along with interstitial lung disease, airway diseases are now regarded as one of the major risk factors of these lung complications and also result in their own problems such as airway obstruction and lung destruction. Bronchiectasis (BE) and bronchiolitis are well-known airway diseases that often develop concurrently. They are found in more than 10–30% of RA subjects and are thought to be caused by persistent inflammation of the airway attributed to the dysregulated immune response in RA. Not infrequently, airway inflammation may provoke destruction of the peripheral airway and lung parenchyma, leading to the formation of a honeycomb-like structure mimicking interstitial lung disease. Control of this inflammation is an urgent issue that needs to be addressed in the future.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Nakajima A, Inoue E, Tanaka E, et al. Mortality and cause of death in Japanese patients with rheumatoid arthritis based on a large observational cohort, IORRA. Scand J Rheumatol. 2010;39:360–7.
Takeuchi T, Kameda H. The Japanese experience with biologic therapies for rheumatoid arthritis. Nat Rev Rheumatol. 2010;6:644–52.
Nakajima A, Saito K, Kojima T, et al. No increased mortality in patients with rheumatoid arthritis treated with biologics: results from the biologics register of six rheumatology institutes in Japan. Mod Rheumatol. 2013;23:945–52.
Doran MF, Crowson CS, Pond GR, O’Fallon WM, Gabriel SE. Frequency of infection in patients with rheumatoid arthritis compared with controls: a population-based study. Arthritis Rheum. 2002;46:2287–93.
Strangfeld A, Eveslage M, Schneider M, et al. Treatment benefit or survival of the fittest: what drives the time-dependent decrease in serious infection rates under TNF inhibition and what does this imply for the individual patient? Ann Rheum Dis. 2011;70:1914–20.
Koike T, Harigai M, Ishiguro N, et al. Safety and effectiveness of adalimumab in Japanese rheumatoid arthritis patients: postmarketing surveillance report of 7740 patients. Mod Rheumatol. 2014;24:390–8.
Wells AU, Denton CP. Interstitial lung disease in connective tissue disease—mechanisms and management. Nat Rev Rheumatol. 2014;10:728–39.
Wilczynska MM, Condliffe AM, McKeon DJ. Coexistence of bronchiectasis and rheumatoid arthritis: revisited. Respir Care. 2013;58:694–701.
Lieberman-Maran L, Orzano IM, Passero MA, Lally EV. Bronchiectasis in rheumatoid arthritis: report of four cases and a review of the literature—implications for management with biologic response modifiers. Semin Arthritis Rheum. 2006;35:379–87.
Tokuda H, Harigai M, Watanabe A, et al. Consensus statements for medical practice: biological agents and lung disease. Abridged English translation by the Japanese Respiratory Society. Respir Investig. 2017;55:229–51.
Boyton RJ, Altmann DM. Bronchiectasis: current concepts in pathogenesis, immunology, and microbiology. Annu Rev Pathol. 2016;11:523–54.
Remy-Jardin M, Remy J, Cortet B, Mauri F, Delcambre B. Lung changes in rheumatoid arthritis: CT findings. Radiology. 1994;193:375–82.
Despaux J, Manzoni P, Toussirot E, Augé B, Cedoz JP, Wendling D. Prospective study of the prevalence of bronchiectasis in rheumatoid arthritis using high-resolution computed tomography. Rev Rhum Engl Ed. 1998;65:453–61.
Perez T, Remy-Jardin M, Cortet B. Airways involvement in rheumatoid arthritis: clinical, functional, and HRCT findings. Am J Respir Crit Care Med. 1998;157:1658–65.
Akira M, Sakatani M, Hara H. Thin-section CT findings in rheumatoid arthritis-associated lung disease: CT patterns and their courses. J Comput Assist Tomogr. 1999;23:941–8.
Terasaki H, Fujimoto K, Hayabuchi N, et al. Respiratory symptoms in rheumatoid arthritis: relation between high resolution CT findings and functional impairment. Radiat Med. 2004;22:179–85.
Wilsher M, Voight L, Milne D, et al. Prevalence of airway and parenchymal abnormalities in newly diagnosed rheumatoid arthritis. Respir Med. 2012;106:1441–6.
Mori S, Cho I, Koga Y, Sugimoto M. Comparison of pulmonary abnormalities on high-resolution computed tomography in patients with early versus longstanding rheumatoid arthritis. J Rheumatol. 2008;35:1513–21.
Tsuchiya Y, Takayanagi N, Sugiura H, et al. Lung diseases directly associated with rheumatoid arthritis and their relationship to outcome. Eur Respir J. 2011;37:1411–7.
Weycker D, Edelsberg J, Oster G, Tino G. Prevalence and economic burden of bronchiectasis. Clin Pulm Med. 2005;12:205–9.
Whitwell F. A study of the pathology and pathogenesis of bronchiectasis. Thorax. 1952;7:213–39.
Morrissey BM. Pathogenesis of bronchiectasis. Clin Chest Med. 2007;28:289–96.
King PT. The pathophysiology of bronchiectasis. Int J Chron Obstruct Pulmon Dis. 2009;4:411–9.
Fuschillo S, De Felice A, Balzano G. Mucosal inflammation in idiopathic bronchiectasis: cellular and molecular mechanisms. Eur Respir J. 2008;31:396–406.
Boyton RJ, Reynolds CJ, Quigley KJ, Altmann DM. Immune mechanisms and the impact of the disrupted lung microbiome in chronic bacterial lung infection and bronchiectasis. Clin Exp Immunol. 2012;171:117–23.
Demoruelle MK, Deane KD, Holers VM. When and where does inflammation begin in rheumatoid arthritis? Curr Opin Rheumatol. 2014;26:64–71.
Naidich DP. Bronchiectasis. In: Naidich DP, Webb WR, Grenier PA, et al., editors. Imaging of the airway; functional and radiologic correlations. Philadelphia: Lippincott WW; 2005. p. 107–45.
Takayanagi N. Biological agents and respiratory infections: causative mechanisms and practice management. Respir Investig. 2015;53:185–200.
Doran MF, Crowson CS, Pond GR, O’Fallon WM, Gabriel SE. Predictors of infection in rheumatoid arthritis. Arthritis Rheum. 2002;46:2294–300.
Swinson DR, Symmons D, Suresh U, Jones M, Booth J. Decreased survival in patients with co-existent rheumatoid arthritis and bronchiectasis. Br J Rheumatol. 1997;36:689–91.
Puéchal X, Génin E, Bienvenu T, Le Jeunne C, Dusser DJ. Poor survival in rheumatoid arthritis associated with bronchiectasis: a family-based cohort study. PLoS One. 2014;9:e110066.
Colby TV, Travis WD. Bronchiolar disorders. In: Travis WD, Colby TV, Koss MN, et al., editors. Non-neoplastic disorders of the lower respiratory tract. Washington, DC: American Registry of Pathology and AFIP; 2002. p. 351–80.
Rangel-Moreno J, Hartson L, Navarro C, Gaxiola M, Selman M, Randall TD. Inducible bronchus-associated lymphoid tissue (iBALT) in patients with pulmonary complications of rheumatoid arthritis. J Clin Invest. 2006;116:3183–94.
Homma S, Kawabata M, Kishi K, et al. Diffuse panbronchiolitis in rheumatoid arthritis. Eur Respir J. 1998;12:444–52.
Sugino K, Hebisawa A, Uekusa T, Hatanaka K, Abe H, Homma S. Histopathological bronchial reconstruction of human bronchiolitis obliterans. Pathol Int. 2011;61:192–201.
Devouassoux G, Cottin V, Lioté H, et al. Characterisation of severe obliterative bronchiolitis in rheumatoid arthritis. Eur Respir J. 2009;33:1053–61.
Hayakawa H, Sato A, Chida K, Toyoshima M, Chida K, Iwata M. Bronchiolar disease in rheumatoid arthritis. Am J Respir Crit Care Med. 1996;154:1531–6.
Yousem SA, Colby TV, Carrington CB. Follicular bronchitis/bronchiolitis. Hum Pathol. 1985;16:700–6.
Mori S, Koga Y, Sugimoto M. Small airway obstruction in patients with rheumatoid arthritis. Mod Rheumatol. 2011;21:164–73.
Tanaka N, Kim JS, Newell JD, et al. Rheumatoid arthritis-related lung diseases: CT findings. Radiology. 2004;232:81–91.
Takemura T. Pathological features of the lung in rheumatoid arthritis. Nihon Kyoubu Rinsho. 2007;66:470–84. (in Japanese).
Tokuda H. Broncho-bronchial disorders in patients with rheumatoid arthritis. Jpn J Clin Radiol. 2015;60:1085–96. (in Japanese).
Cortet B, Perez T, Roux N, et al. Pulmonary function tests and high resolution computed tomography of the lungs in patients with rheumatoid arthritis. Ann Rheum Dis. 1997;56:596–600.
Kohno N, Kyoizumi S, Awaya Y, Fukuhara H, Yamakido M, Akiyama M. New serum indicator of interstitial pneumonitis activity. Sialylated carbohydrate antigen KL-6. Chest. 1989;96:68–73.
Mori S, Koga Y, Sugimoto M. Different risk factors between interstitial lung disease and airway disease in rheumatoid arthritis. Respir Med. 2012;106:1591–9.
Nannini C, Medina-Velasquez YF, et al. Incidence and mortality of obstructive lung disease in rheumatoid arthritis: a population-based study. Arthritis Care Res (Hoboken). 2013;65:1243–50.
Turesson C. Extra-articular rheumatoid arthritis. Curr Opin Rheumatol. 2013;25:360–6.
Gabriel SE, Crowson CS, Kremers HM, et al. Survival in rheumatoid arthritis: a population-based analysis of trends over 40 years. Arthritis Rheum. 2003;48:54–8.
Bartels CM, Bell CL, Shinki K, Rosenthal A, Bridges AJ. Changing trends in serious extra-articular manifestations of rheumatoid arthritis among United State veterans over 20 years. Rheumatology (Oxford). 2010;49:1670–5.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Tokuda, H. (2018). Comprehensive Understanding of Airway Disease in Rheumatoid Arthritis. In: Gono, T., Tokuda, H., Sakai, F., Takemura, T. (eds) Lung Disease Associated with Rheumatoid Arthritis. Springer, Singapore. https://doi.org/10.1007/978-981-10-6750-1_2
Download citation
DOI: https://doi.org/10.1007/978-981-10-6750-1_2
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-10-6749-5
Online ISBN: 978-981-10-6750-1
eBook Packages: MedicineMedicine (R0)